Montine TJ - Search Results

1

4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease.

Montine KS, Kim PJ, Olson SJ, Markesbery WR, Montine TJ. Montine KS, et al. Among authors: montine tj. J Neuropathol Exp Neurol. 1997 Aug;56(8):866-71. doi: 10.1097/00005072-199708000-00004. J Neuropathol Exp Neurol. 1997. PMID: 9258256

2

Crosslinking of apolipoprotein E by products of lipid peroxidation.

Montine TJ, Huang DY, Valentine WM, Amarnath V, Saunders A, Weisgraber KH, Graham DG, Strittmatter WJ. Montine TJ, et al. J Neuropathol Exp Neurol. 1996 Feb;55(2):202-10. doi: 10.1097/00005072-199602000-00009. J Neuropathol Exp Neurol. 1996. PMID: 8786379

3

Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4.

Montine KS, Olson SJ, Amarnath V, Whetsell WO Jr, Graham DG, Montine TJ. Montine KS, et al. Among authors: montine tj. Am J Pathol. 1997 Feb;150(2):437-43. Am J Pathol. 1997. PMID: 9033259 Free PMC article.

4

Neurotoxicity of endogenous cysteinylcatechols.

Montine TJ, Picklo MJ, Amarnath V, Whetsell WO Jr, Graham DG. Montine TJ, et al. Exp Neurol. 1997 Nov;148(1):26-33. doi: 10.1006/exnr.1997.6662. Exp Neurol. 1997. PMID: 9398447

5

Central nervous system lipoproteins in Alzheimer's disease.

Montine TJ, Montine KS, Swift LL. Montine TJ, et al. Among authors: montine ks. Am J Pathol. 1997 Dec;151(6):1571-5. Am J Pathol. 1997. PMID: 9403708 Free PMC article.

6

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.

Roberts LJ 2nd, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, Dettbarn WD, Morrow JD. Roberts LJ 2nd, et al. Among authors: montine tj. J Biol Chem. 1998 May 29;273(22):13605-12. doi: 10.1074/jbc.273.22.13605. J Biol Chem. 1998. PMID: 9593698 Free article.

7

Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.

Montine KS, Reich E, Neely MD, Sidell KR, Olson SJ, Markesbery WR, Montine TJ. Montine KS, et al. Among authors: montine tj. J Neuropathol Exp Neurol. 1998 May;57(5):415-25. doi: 10.1097/00005072-199805000-00005. J Neuropathol Exp Neurol. 1998. PMID: 9596412

8

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.

Montine TJ, Markesbery WR, Morrow JD, Roberts LJ 2nd. Montine TJ, et al. Ann Neurol. 1998 Sep;44(3):410-3. doi: 10.1002/ana.410440322. Ann Neurol. 1998. PMID: 9749613

9

Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins.

Montine KS, Bassett CN, Ou JJ, Markesbery WR, Swift LL, Montine TJ. Montine KS, et al. Among authors: montine tj. J Lipid Res. 1998 Dec;39(12):2443-51. J Lipid Res. 1998. PMID: 9831633 Free article.

10

Increased CSF F2-isoprostane concentration in probable AD.

Montine TJ, Beal MF, Cudkowicz ME, O'Donnell H, Margolin RA, McFarland L, Bachrach AF, Zackert WE, Roberts LJ, Morrow JD. Montine TJ, et al. Neurology. 1999 Feb;52(3):562-5. doi: 10.1212/wnl.52.3.562. Neurology. 1999. PMID: 10025788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

551 results

Search Page

Filters